232 related articles for article (PubMed ID: 23580446)
1. Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells.
Dovizio M; Maier TJ; Alberti S; Di Francesco L; Marcantoni E; Münch G; John CM; Suess B; Sgambato A; Steinhilber D; Patrignani P
Mol Pharmacol; 2013 Jul; 84(1):25-40. PubMed ID: 23580446
[TBL] [Abstract][Full Text] [Related]
2. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
Guillem-Llobat P; Dovizio M; Bruno A; Ricciotti E; Cufino V; Sacco A; Grande R; Alberti S; Arena V; Cirillo M; Patrono C; FitzGerald GA; Steinhilber D; Sgambato A; Patrignani P
Oncotarget; 2016 May; 7(22):32462-77. PubMed ID: 27074574
[TBL] [Abstract][Full Text] [Related]
3. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
Zhang H; Ye Y; Bai Z; Wang S
Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
[TBL] [Abstract][Full Text] [Related]
4. Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.
Chandler HL; Barden CA; Lu P; Kusewitt DF; Colitz CM
Mol Vis; 2007 Apr; 13():677-91. PubMed ID: 17563718
[TBL] [Abstract][Full Text] [Related]
5. The antiplatelet agent revacept prevents the increase of systemic thromboxane A
Alberti S; Zhang Q; D'Agostino I; Bruno A; Tacconelli S; Contursi A; Guarnieri S; Dovizio M; Falcone L; Ballerini P; Münch G; Yu Y; Patrignani P
Sci Rep; 2020 Dec; 10(1):21420. PubMed ID: 33293599
[TBL] [Abstract][Full Text] [Related]
6. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
Mammadova-Bach E; Gil-Pulido J; Sarukhanyan E; Burkard P; Shityakov S; Schonhart C; Stegner D; Remer K; Nurden P; Nurden AT; Dandekar T; Nehez L; Dank M; Braun A; Mezzano D; Abrams SI; Nieswandt B
Blood; 2020 Apr; 135(14):1146-1160. PubMed ID: 32040544
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression.
Rodriguez DA; Tapia JC; Fernandez JG; Torres VA; Muñoz N; Galleguillos D; Leyton L; Quest AF
Mol Biol Cell; 2009 Apr; 20(8):2297-310. PubMed ID: 19244345
[TBL] [Abstract][Full Text] [Related]
8. The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke.
Goebel S; Li Z; Vogelmann J; Holthoff HP; Degen H; Hermann DM; Gawaz M; Ungerer M; Münch G
PLoS One; 2013; 8(7):e66960. PubMed ID: 23935828
[TBL] [Abstract][Full Text] [Related]
9. Nicotine increases colon cancer cell migration and invasion through epithelial to mesenchymal transition (EMT): COX-2 involvement.
Dinicola S; Masiello MG; Proietti S; Coluccia P; Fabrizi G; Catizone A; Ricci G; de Toma G; Bizzarri M; Cucina A
J Cell Physiol; 2018 Jun; 233(6):4935-4948. PubMed ID: 29215713
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.
Tammali R; Saxena A; Srivastava SK; Ramana KV
J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240
[TBL] [Abstract][Full Text] [Related]
11. TNFα-activated stromal COX-2 signalling promotes proliferative and invasive potential of colon cancer epithelial cells.
Zhu M; Zhu Y; Lance P
Cell Prolif; 2013 Aug; 46(4):374-81. PubMed ID: 23869759
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.
Graff J; Skarke C; Klinkhardt U; Watzer B; Harder S; Seyberth H; Geisslinger G; Nüsing RM
J Thromb Haemost; 2007 Dec; 5(12):2376-85. PubMed ID: 17916229
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.
Colucci R; Blandizzi C; Ghisu N; Florio T; Del Tacca M
Br J Pharmacol; 2008 Sep; 155(2):198-209. PubMed ID: 18587421
[TBL] [Abstract][Full Text] [Related]
15. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
Walmesley AJ; Zweiri J; Christmas SE; Watson AJ
J Immunother; 2007 Sep; 30(6):614-23. PubMed ID: 17667525
[TBL] [Abstract][Full Text] [Related]
16. TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1.
Takai E; Tsukimoto M; Kojima S
PLoS One; 2013; 8(10):e76346. PubMed ID: 24098479
[TBL] [Abstract][Full Text] [Related]
17. Silencing of COX-2 by RNAi modulates epithelial-mesenchymal transition in breast cancer cells partially dependent on the PGE2 cascade.
Cao J; Yang X; Li WT; Zhao CL; Lv SJ
Asian Pac J Cancer Prev; 2014; 15(22):9967-72. PubMed ID: 25520137
[TBL] [Abstract][Full Text] [Related]
18. The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell- like phenotype in the colon.
Aggarwal A; Prinz-Wohlgenannt M; Gröschel C; Tennakoon S; Meshcheryakova A; Chang W; Brown EM; Mechtcheriakova D; Kállay E
Mol Cancer; 2015 Mar; 14():61. PubMed ID: 25879211
[TBL] [Abstract][Full Text] [Related]
19. Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk.
Dovizio M; Alberti S; Sacco A; Guillem-Llobat P; Schiavone S; Maier TJ; Steinhilber D; Patrignani P
Biochem Soc Trans; 2015 Aug; 43(4):707-14. PubMed ID: 26551717
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
Zhang Y; Hoda MN; Zheng X; Li W; Luo P; Maddipati KR; Seki T; Ergul A; Wang MH
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R693-703. PubMed ID: 24990856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
